Key facts
- This page summarizes EcoR1 Capital, LLC's Form 4 filing for Voyager Therapeutics, Inc. (VYGR).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2023, 17:26.
EcoR1 Capital, LLC - 09 Jan 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VYGR
- Reported as of
- 09 Jan 2023
- Net transaction value
- -$7,142,343
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2023, 17:26:21 UTC
- Prior SEC filing
- 06 Jan 2023
- Next SEC filing
- 12 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- Oleg Nodelman, Manager of EcoR1 Capital, LLC
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
EcoR1 Capital, LLC filed Form 4 for Voyager Therapeutics, Inc. (VYGR) on 11 Jan 2023.
Change
- Previous filing in this sequence was filed on 06 Jan 2023.
- Current net transaction value: -$7,142,343.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VYGR
transaction
Common Stock
Sale
- Transaction value
- $3,498,295
- Shares
- -456,000
- Change %
- -9.6%
- Price
- $7.67
- Shares after
- 4,297,907
- Date
- 09 Jan 2023
- Ownership
- See Note 1
- Footnotes
- F1, F2, F3
VYGR
transaction
Common Stock
Sale
- Transaction value
- $2,709,433
- Shares
- -336,400
- Change %
- -7.8%
- Price
- $8.05
- Shares after
- 3,961,507
- Date
- 10 Jan 2023
- Ownership
- See Note 1
- Footnotes
- F1, F4, F5
VYGR
transaction
Common Stock
Sale
- Transaction value
- $934,615
- Shares
- -110,000
- Change %
- -2.8%
- Price
- $8.50
- Shares after
- 3,851,507
- Date
- 11 Jan 2023
- Ownership
- See Note 1
- Footnotes
- F1, F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds, and Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests the
Footnote F2
Qualified Fund sold 429,505 shares of the Common Stock sold in this transaction.
Footnote F3
After this transaction, Qualified Fund directly owned 3,999,933 shares of Common Stock.
Footnote F4
Qualified Fund sold 268,985 shares of the Common Stock sold in this transaction.
Footnote F5
After this transaction, Qualified Fund directly owned 3,730,948 shares of Common Stock.
Footnote F6
Qualified Fund sold 103,609 shares of the Common Stock sold in this transaction.
Footnote F7
After this transaction, Qualified Fund directly owned 3,627,339 shares of Common Stock.